Abstract
Gitelman’s syndrome (GS), an autosomal recessive disorder caused by a defect of the thiazide-sensitive NaCl cotransporter (TSC) at the distal tubule, is characterized by hyperreninemic hyperaldosteronism with normal or low blood pressure, hypokalemia, metabolic alkalosis, hypomagnesemia and hypocalciuria. An 18-yr-old Japanese man was admitted to our hospital with a history of muscle weakness and transient tetanic episodes. He showed hypocalcemia in addition to hypokalemia, severe hypomagnesemia, hypocalciuria and hyperreninemic hyperaldosteronism with normal blood pressure. Furthermore, bone mineral density at the lumbar spine revealed osteopenia. A diagnosis of GS was made on the basis of clinical features, laboratory data and renal function test. The electrolyte imbalance was corrected and bone mineral density was slightly increased with chronic treatment of magnesium and potassium salts. Genetic analysis revealed that TSC gene of the patient has a heterozygous C to A nucleotide substitution at position 545 in exon 4, which causes a threonine (Thr) to lysine (Lys) substitution at position 180. This is a rare case of GS with hypocalcemia and osteopenia which could be caused by severe hypomagnesemia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gitelman H, Graham J, Welt L. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 1966, 79: 92–6.
Simon DB, Nelson WC, Bia MJ, et al. Gitelman’s variant of Bartter’s syndrome, inherited hypokalemic alkalosis, is caused by mutations in the thiazide-sensitive NaCl cotransporter. Nat Genet 1996, 12: 24–30.
Bettinelli A, Bianchetti MG, Girardin E, et al. Use of calcium excretion values to distinguish two forms of primary renal tubular hypokalemic alkalosis: Bartter and Gitelman syndromes. J Pediatr 1992, 120: 38–43.
Stein JH. The pathogenetic spectrum of Bartter’s syndrome. Kidney Int 1985, 28: 85–93.
Shaer AJ. Inherited Primary Renal Tubular Hypokalemic Alkalosis: A review of Gitalman and Bartter syndromes. Am J Med Sci 2001, 322: 316–32.
Turman MA. Concomitant occurrence of Gitelman and Bartter syndromes in the same family? Pediatr Nephrol 1998, 12: 23–5.
Simon DB, Lifton RP. The molecular basis of inherited hypokalemic alkalosis: Bartter’s and Gitelman’s syndromes. Am Physiol Soc 1996, 271: F961–6.
Jeck N, Konrad M, Peters M, et al. Mutations in the chloride channel gene, CLCNKB, leading to a mixed Bartter-Gitel-man phenotype. Pediatr Res 2000, 48: 754–8.
Zelikovic I, Szargel R, Hawash A, et al. A novel mutation in the chloride channel gene, CLCNKB, as a cause of Gitelman and Bartter syndromes. Kidney Int 2003, 63: 24–32.
Tsukamoto T, Kobayashi T, Kawamoto K, Fukase M, Chihara K. Possible discrimination of Gitelman’s syndrome from Bartter’s syndrome by renal clearance study: report of two cases. Am J Kidney Dis 1995, 25: 637–41.
Tajima T, Kobayashi Y, Abe S, et al. Two novel mutations of thiazide-sensitive NaCl cotransporter (TSC) gene in two sporadic Japanese patients with Gitelman’s syndrome. Endocr J 2002, 49: 91–6.
Bettinelli A, Bianchetti MG, Borella P, et al. Genetic heterogeneity in tubular hypomagnesemia-hypokalemia with hypocalciuria (Gitelman’s syndrome). Kidney Int 1995, 47: 547–51.
Bettinelli A, Basilico E, Metta MG, Borella P, Jaeger P, Bianchetti MG. Magnesium supplementation in Gitelman’s syndrome. Pediatric Nephrol 1999, 13: 311–4.
Pantanetti P, Arnaldi G, Balercia G, Mantero F, Giacchetti G. Severe hypomagnesaemia-induced hypocalcaemia in a patient with Gitelman’s syndrome. Clin Endocrinol (Oxf) 2002, 56: 413–8.
Anast CS, Mohs JM, Kaplan SL, Burns TW. Evidence for parathyroid failure in magnesium deficiency. Science 1972, 177: 606–8.
Anast CS, Winnacker JL, Forte LR, Burns TW. Impaired release of parathyroid hormone in magnesium deficiency. J Clin Endocrinol Metab 1976, 42: 707–17.
Rude RK, Oldham SB, Sharp CF, Singer FR. Parathyroid hormone secretion in magnesium dificiency. J Clin Endocrinol Metab 1978, 47: 800–6.
Bianchetti MG, Bettinelli A, Casez JP, et al. Evidence for disturbed regulation of calciotropic hormone metabolism in Gitelman’s syndrome. J Clin Endocrinol Metab 1995, 80: 224–8.
Laroche M, Mazieres B. Beneficial effect of a thiazide diuretic on bone mineral density in male osteoporosis with hypercalciuria. Clin Exp Rheumatol 1998, 16: 109–10.
Cruz DN, Simon DB, Lifton RP. Inactivating mutations in the NaCl co-transporter is associated with high bone density. J Am Soc Nephrol 1999, 10: A3024 (abstract).
Boncimino K, McMahon DJ, Addesso V, Bilezikian JP, Shane E. Magnesium deficiency and bone loss after cardiac transplantation. J Bone Miner Res 1999, 14: 295–303.
Egami I, Wakai K, Kunimoto H, et al. Association of lifestyle factors with bone mineral density among male university students in Japan. J Epidemiol 2003, 13: 48–55.
Rude RK. Magnesium homeostasis. In: Bilezikian JP, Raisz LG, Rodan GA eds. Principles of Bone Biology. New York: Academic Press. 1996, 277–93.
Monkawa T, Kurihara I, Kobayashi K, Hayashi M, Saruta T. Novel mutations in thiazide-sensitive NaCl cotransporter gene of patients with Gitelman’s syndrome. J Am Soc Nephrol 2000, 11: 65–70.
Yoo T, Lee S, Yoon K, et al. Identification of novel mutations in NaCl cotransporter gene in a Korean patient with atypical Gitelman’s syndrome. Am J Kidney Dis 2003, 42: 11–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakamura, A., Shimizu, C., Nagai, S. et al. A rare case of Gitelman’s syndrome presenting with hypocalcemia and osteopenia. J Endocrinol Invest 28, 464–468 (2005). https://doi.org/10.1007/BF03347229
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347229